von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.

J H Jansson, T K Nilsson, O Johnson

Department of Internal Medicine, Skellefteå Hospital, Sweden.

OBJECTIVE--To evaluate as predictors of reinfarction and mortality tissue plasminogen activator antigen and activity before and after venous occlusion, plasminogen activator inhibitor, von Willebrand factor, and established risk factors. DESIGN--Prospective study with a mean observation time of 4.9 years. SETTING--Secondary referral centre, the Department of Internal Medicine, University Hospital of Umeå. PATIENTS--123 consecutive survivors of myocardial infarction under the age of 70 years. MAIN OUTCOME MEASURES--Reinfarction and deaths from all causes. RESULTS--23 patients died and 36 patients had at least one reinfarction. High concentrations of von Willebrand factor were independently associated with both reinfarction and mortality. A history of angina at entry into the study was also independently associated with reinfarction and mortality. Hypertension was independently associated with mortality but not with reinfarction. None of the fibrinolytic or lipid variables was associated with reinfarction or death. CONCLUSION--A high concentration of von Willebrand factor was a novel index of increased risk for reinfarction and mortality in survivors of myocardial infarction.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Relevant Article

von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death

Ad Blann, Marilyn Porter, Cn McCollum, and Jan-Håkan Jansson
Heart 1992 68: 635-636. [PDF]

This article has been cited by other articles:

• Spiel, A. O., Gilbert, J. C., Jilma, B. (2008). Von Willebrand Factor in Cardiovascular Disease: Focus on Acute Coronary Syndromes. Circulation 117: 1449-1459 [Abstract] [Full Text]  
• Homoncik, M., Gessl, A., Ferlitsch, A., Jilma, B., Vierhapper, H. (2007). Altered Platelet Plug Formation in Hyperthyroidism and Hypothyroidism. J. Clin. Endocrinol. Metab. 92: 3006-3012 [Abstract] [Full Text]  
• Der, H., Kerekes, G., Veres, K., Szodoray, P., Toth, J., Lakos, G., Szegedi, G., Soltesz, P. (2007). Impaired endothelial function and increased carotid intima-media thickness in association with elevated von Willebrand antigen level in primary antiphospholipid syndrome. Lupus 16: 497-503 [Abstract]  
• Chong, A. Y., Lip, G. Y.H., Freestone, B., Blann, A. D. (2006). Increased circulating endothelial cells in acute heart failure: Comparison with von Willebrand factor and soluble E-selectin. Eur J Heart Fail 8: 167-172 [Abstract] [Full Text]  
• Tomokiyo, K., Kamikubo, Y., Hanada, T., Araki, T., Nakatomi, Y., Ogata, Y., Jung, S. M., Nakagaki, T., Moroi, M. (2005). Von Willebrand factor accelerates platelet adhesion and thrombus formation on a collagen surface in platelet-reduced blood under flow conditions. Blood 105: 1078-1084 [Abstract] [Full Text]  
• Frossard, M., Fuchs, I., Leitner, J. M., Hsieh, K., Vlcek, M., Losert, H., Domanovits, H., Schreiber, W., Laggner, A. N., Jilma, B. (2004). Platelet Function Predicts Myocardial Damage in Patients With Acute Myocardial Infarction. Circulation 110: 1392-1397 [Abstract] [Full Text]  
• Robinson, G V, Pepperell, J C T, Segal, H C, Davies, R J O, Stradling, J R (2004). Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trials. Thorax 59: 777-782 [Abstract] [Full Text]  
• Dunn, E. J., Ariens, R. A., de Lange, M., Snieder, H., Turney, J. H., Spector, T. D., Grant, P. J. (2004). Genetics of fibrin clot structure: a twin study. Blood 103: 1735-1740 [Abstract] [Full Text]  
• Lowe, G.D.O., Danesh, J., Lewington, S., Walker, M., Lennon, L., Thomson, A., Rumley, A., Whincup, P.H. (2004). Tissue plasminogen activator antigen and coronary heart disease: Prospective study and meta-analysis. Eur Heart J 25: 252-259 [Abstract] [Full Text]  
• Smith, J. C., Lane, H. A., Lewis, J., Dann, S., Goodfellow, J., Collins, P., Evans, L. M., Scanlon, M. F., Davies, J. S. (2003). Endothelial Function and Coagulant Factors in Growth Hormone-Treated Hypopituitary Adults Receiving Desmopressin. J. Clin. Endocrinol. Metab. 88: 2152-2156 [Abstract] [Full Text]  
• Chong, A.-Y., Blann, A.D., Lip, G.Y.H. (2003). Assessment of endothelial damage and dysfunction: observations in relation to heart failure. QJM 96: 253-267 [Full Text]  
• Rabbani, L. E., Seminario, N. A., Sciacca, R. R., Chen, H. J., Giardina, E.-G. V. (2002). Oral conjugated equine estrogen increases plasma von Willebrand factor in postmenopausal women. J Am Coll Cardiol 40: 1991-1999 [Abstract] [Full Text]  
• Whincup, P.H., Danesh, J., Walker, M., Lennon, L., Thomson, A., Appleby, P., Rumley, A., Lowe, G.D.O. (2002). von Willebrand factor and coronary heart disease. Prospective study and meta-analysis. Eur Heart J 23: 1764-1770 [Abstract] [Full Text]  
• Mills, J.D., Mansfield, M.W., Grant, P.J. (2002). Elevated fibrinogen in the healthy male relatives of patients with severe, premature coronary artery disease. Eur Heart J 23: 1276-1281 [Abstract]  
• Romano, M., Pomilio, M., Vigneri, S., Falco, A., Chiesa, P. L., Chiarelli, F., Davi, G. (2001). Endothelial Perturbation in Children and Adolescents With Type 1 Diabetes: Association with markers of the inflammatory reaction. Diabetes Care 24: 1674-1678 [Abstract] [Full Text]  
• Sramek, A., Reiber, J.H.C., Gerrits, W.B.J., Rosendaal, F.R. (2001). Decreased Coagulability Has No Clinically Relevant Effect on Atherogenesis: Observations in Individuals With a Hereditary Bleeding Tendency. Circulation 104: 762-767 [Abstract] [Full Text]  
• Bogaty, P., Poirier, P., Simard, S., Boyer, L., Solymoss, S., Dagenais, G. R. (2001). Biological Profiles in Subjects With Recurrent Acute Coronary Events Compared With Subjects With Long-Standing Stable Angina. Circulation 103: 3062-3068 [Abstract] [Full Text]  
• Gibbs, C. R., Blann, A. D., Watson, R. D. S., Lip, G. Y. H. (2001). Abnormalities of Hemorheological, Endothelial, and Platelet Function in Patients With Chronic Heart Failure in Sinus Rhythm : Effects of Angiotensin-Converting Enzyme Inhibitor and {beta}-Blocker Therapy. Circulation 103: 1746-1751 [Abstract] [Full Text]  
• Fiorina, P., La Rocca, E., Venturini, M., Minicucci, F., Fermo, I., Paroni, R., D’Angelo, A., Sblendido, M., Di Carlo, V., Cristallo, M., Del Maschio, A., Pozza, G., Secchi, A. (2001). Effects of Kidney-Pancreas Transplantation on Atherosclerotic Risk Factors and Endothelial Function in Patients With Uremia and Type 1 Diabetes. Diabetes 50: 496-501 [Abstract] [Full Text]  
• Roest, M., Banga, J. D., Grobbee, D. E., de Groot, P. G., Sixma, J. J., Tempelman, M. J., van der Schouw, Y. T. (2000). Homozygosity for 807 T Polymorphism in {alpha}2 Subunit of Platelet {alpha}2{beta}1 Is Associated With Increased Risk of Cardiovascular Mortality in High-Risk Women. Circulation 102: 1645-1650 [Abstract] [Full Text]  
• Van de Water, N. S., French, J. K., Lund, M., Hyde, T. A., White, H. D., Browett, P. J. (2000). Prevalence of factor v leiden and prothrombin variant g20210a in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction. J Am Coll Cardiol 36: 717-722 [Abstract] [Full Text]  
• Wiman, B., Andersson, T., Hallqvist, J., Reuterwall, C., Ahlbom, A., deFaire, U. (2000). Plasma Levels of Tissue Plasminogen Activator/Plasminogen Activator Inhibitor-1 Complex and von Willebrand Factor Are Significant Risk Markers for Recurrent Myocardial Infarction in the Stockholm Heart Epidemiology Program (SHEEP) Study. Arterioscler. Thromb. Vasc. Bio. 20: 2019-2023 [Abstract] [Full Text]  
• Souto, J. C., Almasy, L., Muniz-Diaz, E., Soria, J. M., Borrell, M., Bayen, L., Mateo, J., Madoz, P., Stone, W., Blangero, J., Fontcuberta, J. (2000). Functional Effects of the ABO Locus Polymorphism on Plasma Levels of von Willebrand Factor, Factor VIII, and Activated Partial Thromboplastin Time. Arterioscler. Thromb. Vasc. Bio. 20: 2024-2028 [Abstract] [Full Text]  
• White, H.D. (2000). International differences: selection, noise, or real?. Eur Heart J 21: 339-342  
• Lane, D. A., Grant, P. J. (2000). Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 95: 1517-1532 [Full Text]  
• Sonoda, A., Murata, M., Ito, D., Tanahashi, N., Ohta, A., Tada, Y., Takeshita, E., Yoshida, T., Saito, I., Yamamoto, M., Ikeda, Y., Fukuuchi, Y., Watanabe, K. (2000). Association Between Platelet Glycoprotein Ib{alpha} Genotype and Ischemic Cerebrovascular Disease. Stroke 31: 493-497 [Abstract] [Full Text]  
• Jager, A., van Hinsbergh, V. W. M., Kostense, P. J., Emeis, J. J., Yudkin, J. S., Nijpels, G., Dekker, J. M., Heine, R. J., Bouter, L. M., Stehouwer, C. D. A. (1999). von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects : The Hoorn Study. Arterioscler. Thromb. Vasc. Bio. 19: 3071-3078 [Abstract] [Full Text]  
• Bilora, F., Dei Rossi, C., Girolami, B., Casonato, A., Zanon, E., Bertomoro, A., Girolami, A. (1999). Do Hemophilia A and von Willebrand Disease Protect Against Carotid Atherosclerosis? A Comparative Study Between . Coagulopathics and Normal Subjects by Means of Carotid Echo-Color Doppler Scan. CLIN APPL THROMB HEMOST 5: 232-235 [Abstract]  
• Siegel, A. J., Sholar, M. B., Mendelson, J. H., Lukas, S. E., Kaufman, M. J., Renshaw, P. F., McDonald, J. C., Lewandrowski, K. B., Apple, F. S., Stec, J. J., Lipinska, I., Tofler, G. H., Ridker, P. M. (1999). Cocaine-Induced Erythrocytosis and Increase in von Willebrand Factor: Evidence for Drug-Related Blood Doping and Prothrombotic Effects. Arch Intern Med 159: 1925-1929 [Abstract] [Full Text]  
• Folsom, A. R., Rosamond, W. D., Shahar, E., Cooper, L. S., Aleksic, N., Nieto, F. J., Rasmussen, M. L., Wu, K. K. (1999). Prospective Study of Markers of Hemostatic Function With Risk of Ischemic Stroke. Circulation 100: 736-742 [Abstract] [Full Text]  
• de Valk-de Roo, G. W., Stehouwer, C. D.A., Lambert, J., Schalkwijk, C. G., van der Mooren, M. J., Kluft, C., Netelenbos, C. (1999). Plasma Homocysteine Is Weakly Correlated with Plasma Endothelin and von Willebrand Factor but not with Endothelium-dependent Vasodilatation in Healthy Postmenopausal Women. Clin. Chem. 45: 1200-1205 [Abstract] [Full Text]  
• Keightley, A. M., Lam, Y. M., Brady, J. N., Cameron, C. L., Lillicrap, D. (1999). Variation at the von Willebrand Factor (vWF) Gene Locus Is Associated With Plasma vWF:Ag Levels: Identification of Three Novel Single Nucleotide Polymorphisms in the vWF Gene Promoter. Blood 93: 4277-4283 [Abstract] [Full Text]  
• Gibbons, R. J., Chatterjee, K., Daley, J., Douglas, J. S., Fihn, S. D., Gardin, J. M., Grunwald, M. A., Levy, D., Lytle, B. W., O'Rourke, R. A., Schafer, W. P., Williams, S. V., Ritchie, J. L., Gibbons, R. J., Cheitlin, M. D., Eagle, K. A., Gardner, T. J., Garson, A. Jr, Russell, R. O., Ryan, T. J., Smith, S. C. Jr (1999). ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol 33: 2092-2197 [Full Text]  
• Eto, K., Isshiki, T., Yamamoto, H., Takeshita, S., Ochiai, M., Yokoyama, N., Yoshimoto, R., Ikeda, Y., Sato, T. (1999). AJvW-2, an Anti-vWF Monoclonal Antibody, Inhibits Enhanced Platelet Aggregation Induced by High Shear Stress in Platelet-Rich Plasma From Patients With Acute Coronary Syndromes. Arterioscler. Thromb. Vasc. Bio. 19: 877-882 [Abstract] [Full Text]  
• Wamala, S. P., Murray, M. A., Horsten, M., Eriksson, M., Schenck-Gustafsson, K., Hamsten, A., Silveira, A., Orth-Gomer, K. (1999). Socioeconomic Status and Determinants of Hemostatic Function in Healthy Women. Arterioscler. Thromb. Vasc. Bio. 19: 485-492 [Abstract] [Full Text]  
• Goto, S., Sakai, H., Goto, M., Ono, M., Ikeda, Y., Handa, S., Ruggeri, Z. M. (1999). Enhanced Shear-Induced Platelet Aggregation in Acute Myocardial Infarction. Circulation 99: 608-613 [Abstract] [Full Text]  
• Beguin, S., Kumar, R., Keularts, I., Seligsohn, U., Coller, B.S., Hemker, H.C. (1999). Fibrin-Dependent Platelet Procoagulant Activity Requires GPIb Receptors and von Willebrand Factor. Blood 93: 564-570 [Abstract] [Full Text]  
• Brulez, H., van Guldener, C., Donker, A., ter Wee, P. (1999). The impact of an amino acids-based peritoneal dialysis fluid on plasma total homocysteine levels, lipid profile and body fat mass. Nephrol Dial Transplant 14: 154-159 [Abstract]  
• Thogersen, A. M., Jansson, J.-H., Boman, K., Nilsson, T. K., Weinehall, L., Huhtasaari, F., Hallmans, G. (1998). High Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma Precede a First Acute Myocardial Infarction in Both Men and Women : Evidence for the Fibrinolytic System as an Independent Primary Risk Factor. Circulation 98: 2241-2247 [Abstract] [Full Text]  
• Jansson, J-H, Nilsson, T K, Johnson, O (1998). von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction. Heart 80: 334-337 [Abstract] [Full Text]  
• Mannucci, P. M. (1998). von Willebrand Factor : A Marker of Endothelial Damage?. Arterioscler. Thromb. Vasc. Bio. 18: 1359-1362 [Full Text]  
• Murata, M., Matsubara, Y., Kawano, K., Zama, T., Aoki, N., Yoshino, H., Watanabe, G., Ishikawa, K., Ikeda, Y. (1997). Coronary Artery Disease and Polymorphisms in a Receptor Mediating Shear Stress–Dependent Platelet Activation. Circulation 96: 3281-3286 [Abstract] [Full Text]  
• Jansson, J.-H., Boman, K., Brannstrom, M., Nilsson, T. K. (1997). High Concentration of Thrombomodulin in Plasma Is Associated With Hemorrhage : A Prospective Study in Patients Receiving Long-term Anticoagulant Treatment. Circulation 96: 2938-2943 [Abstract] [Full Text]  
• Nieto, F. J., Sorlie, P., Comstock, G. W., Wu, K., Adam, E., Melnick, J. L., Szklo, M. (1997). Cytomegalovirus Infection, Lipoprotein(a), and Hypercoagulability: An Atherogenic Link?. Arterioscler. Thromb. Vasc. Bio. 17: 1780-1785 [Abstract] [Full Text]  
• Folsom, A. R., Wu, K. K., Rosamond, W. D., Sharrett, A. R., Chambless, L. E. (1997). Prospective Study of Hemostatic Factors and Incidence of Coronary Heart Disease : The Atherosclerosis Risk in Communities (ARIC) Study. Circulation 96: 1102-1108 [Abstract] [Full Text]  
• Galbusera, M., Zoja, C., Donadelli, R., Paris, S., Morigi, M., Benigni, A., Figliuzzi, M., Remuzzi, G., Remuzzi, A. (1997). Fluid Shear Stress Modulates von Willebrand Factor Release From Human Vascular Endothelium. Blood 90: 1558-1564 [Abstract] [Full Text]  
• Favaloro, E. J., Mehrabani, P. A., Koutts, J. (1997). Laboratory Assessment of von Willebrand Factor: Altered Interpretation of Laboratory Data, and Altered Diagnosis of von Willebrand's Disease. CLIN APPL THROMB HEMOST 3: 110-118 [Abstract]  
• Mansfield, M. W., Heywood, D. M., Grant, P. J. (1996). Circulating Levels of Factor VII, Fibrinogen, and von Willebrand Factor and Features of Insulin Resistance in First-Degree Relatives of Patients With NIDDM. Circulation 94: 2171-2176 [Abstract] [Full Text]  
• Thompson, S.G., Fechtrup, C., Squire, E., Heyse, U., Breithardt, G., van de Loo, J.C.W., Kienast, J. (1996). Antithrombin III and Fibrinogen as Predictors of Cardiac Events in Patients With Angina Pectoris. Arterioscler. Thromb. Vasc. Bio. 16: 357-362 [Abstract] [Full Text]  
• Cigolini, M., Targher, G., Andreis, I.A. B., Tonoli, M., Agostino, G., De Sandre, G. (1996). Visceral Fat Accumulation and Its Relation to Plasma Hemostatic Factors in Healthy Men. Arterioscler. Thromb. Vasc. Bio. 16: 368-374 [Abstract] [Full Text]  
• Cortellaro, M., Baldassarre, D., Cofrancesco, E., Tremoli, E., Colombo, A., Boschetti, C., Paoletti, R. (1996). Relation Between Hemostatic Variables and Increase of Common Carotid Intima-Media Thickness in Patients With Peripheral Arterial Disease. Stroke 27: 450-454 [Abstract] [Full Text]  
• Jensen, J. S. (1995). Renal and Systemic Transvascular Albumin Leakage in Severe Atherosclerosis. Arterioscler. Thromb. Vasc. Bio. 15: 1324-1329 [Abstract] [Full Text]  
• Murakami, T., Komiyama, Y., Masuda, M., Karakawa, M., Iwasaka, T., Takahashi, H. (1995). Evaluation of Factor XIa–{alpha}1-Antitrypsin in Plasma, a Contact Phase–Activated Coagulation Factor–Inhibitor Complex, in Patients With Coronary Artery Disease. Arterioscler. Thromb. Vasc. Bio. 15: 1107-1113 [Abstract] [Full Text]  
• Thompson, S. G., Kienast, J., Pyke, S. D.M., Haverkate, F., van de Loo, J. C.W., The European Concerted Action on Thrombosis and Di, (1995). Hemostatic Factors and the Risk of Myocardial Infarction or Sudden Death in Patients with Angina Pectoris. NEJM 332: 635-641 [Abstract] [Full Text]  
• Hamsten, A. (1995). Hemostatic Function and Coronary Artery Disease. NEJM 332: 677-678 [Full Text]  
• Ames, P. R.J. (1994). Medical Perspective Antiphospholipid Antibodies, Thrombosis and Atherosclerosis in Systemic Lupus Erythematosus: a Unifying 'Membrane Stress Syndrome' Hypothesis. Lupus 3: 371-377